Concordance between radioimmunoassay and fixed cell‐based assay in subjects without myasthenia gravis: optimizing the diagnostic approach
European Journal of Neurology · 2024
DOI: 10.1111/ene.16435 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Silvia Falso und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy. Hauptthemen laut MEDLINE: Radioimmunoassay, Receptors, Cholinergic, Myasthenia Gravis, Autoantibodies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
Background and Purpose Acetylcholine receptor antibody (AChR‐Ab) detection is crucial in myasthenia gravis (MG) diagnosis and, currently, the radioimmunoassay (RIA) is the gold standard. However, RIA may detect AChR‐Ab against nonpathogenic intracellular epitopes. In this study, we performed fixed cell‐based assay (F‐CBA) in RIA‐AChR‐Ab positive subjects without MG symptoms, to assess whether F‐CBA could show a higher specificity compared to RIA in detecting pathogenic Abs.
Methods
We reviewed medical records of patients referred to our MG outpatient clinic because of RIA‐AChR‐Ab detection. MG diagnosis was based on clinical examination, electrophysiology and Ab detection. AChR‐Abs were tested by RIA in the whole cohort. Serum samples from RIA‐positive asymptomatic subjects were retested by F‐CBA.
Results
Of 605 subjects who tested RIA‐AChR‐Ab positive, MG diagnosis was confirmed in 599. Six subjects were RIA‐AChR‐Ab positive although they had never had MG symptoms; in four of these subjects AChR‐Abs were not detected by F‐CBA, whereas the remaining two (both non‐MG thymoma cases) were positive also by F‐CBA.
Conclusions
RIA false positivity for AChR‐Ab is very rare. Previous literature has demonstrated that F‐CBA has higher sensitivity than RIA for MG, especially in ocular cases. Our preliminary results show that, in rare instances, F‐CBA may be more specific than RIA for MG diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy.
- Department of Chemistry and Clinical Biochemistry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
- Neurology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
ORCID-Profile: Eleonora Sabatelli, Amelia Evoli, Raffaele Iorio
Förderung
- NINDS NIH HHS
Zitieren
APA
Falso, S., Marini, S., Carrozza, C., Sabatelli, E., Mascagna, G., Marini, M., Morroni, J., Evoli, A., & Iorio, R. (2024). Concordance between radioimmunoassay and fixed cell‐based assay in subjects without myasthenia gravis: optimizing the diagnostic approach. European Journal of Neurology. https://doi.org/10.1111/ene.16435
Vancouver
Falso S, Marini S, Carrozza C, Sabatelli E, Mascagna G, Marini M, et al. Concordance between radioimmunoassay and fixed cell‐based assay in subjects without myasthenia gravis: optimizing the diagnostic approach. European Journal of Neurology. 2024. doi:10.1111/ene.16435
BibTeX
@article{Falso2024,
author = {Falso, Silvia and Marini, Sofia and Carrozza, Cinzia and Sabatelli, Eleonora and Mascagna, Giovanni and Marini, Martina and Morroni, Jacopo and Evoli, Amelia and Iorio, Raffaele},
title = {Concordance between radioimmunoassay and fixed cell‐based assay in subjects without myasthenia gravis: optimizing the diagnostic approach},
journal = {European Journal of Neurology},
year = {2024},
doi = {10.1111/ene.16435}
}
EUVIMED